Answers are grounded in this paper and cite their sources.
The rate of pump thrombosis related to the use of the HeartMate II has been increasing at our centers and is associated with substantial morbidity and mortality.
No takes yet. Share an insight, caveat, or question.
Starling et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: